NON-PROLIFERATIVE DIABETIC RETINOPATHY
Clinical trials for NON-PROLIFERATIVE DIABETIC RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new NON-PROLIFERATIVE DIABETIC RETINOPATHY trials appear
Sign up with your email to follow new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye implant could slow vision loss from diabetes
Disease control Recruiting nowThis study tests an eye implant called OTX-TKI that slowly releases medicine to treat non-proliferative diabetic retinopathy, a common diabetes complication that can lead to vision loss. About 930 adults with moderate to severe disease will receive either the implant or a sham pr…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE3 • Sponsor: Ocular Therapeutix, Inc. • Aim: Disease control
Last updated May 26, 2026 11:10 UTC
-
New drug ANXV aims to save sight in diabetic and vein occlusion patients
Disease control Recruiting nowThis early study tests a new drug, ANXV, in 12 adults with diabetic retinopathy or retinal vein occlusion. The main goal is to check if ANXV is safe and if it can improve vision or reduce the need for other treatments. Participants receive ANXV as a 30-minute infusion daily for 5…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE2 • Sponsor: Annexin Pharmaceuticals AB • Aim: Disease control
Last updated May 20, 2026 11:55 UTC